|
1
|
Mirabello L, Troisi RJ and Savage SA:
International osteosarcoma incidence patterns in children and
adolescents, middle ages and elderly persons. Int J Cancer.
125:229–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ritter J and Bielack SS: Osteosarcoma. Ann
Oncol. 21:(Suppl 7). vii320–vii325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Isakoff MS, Bielack SS, Meltzer P and
Gorlick R: Osteosarcoma: current treatment and a collaborative
pathway to success. J Clin Oncol. 33:3029–3035. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Klein MJ and Siegal GP: Osteosarcoma:
anatomic and histologic variants. Am J Clin Pathol. 125:555–581.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ren HY, Sun LL, Li HY and Ye ZM:
Prognostic significance of serum alkaline phosphatase level in
osteosarcoma: a meta-analysis of published data. BioMed Res Int.
2015:1608352015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Y, Zhang L, Zhang G, Li S, Duan J,
Cheng J, Ding G, Zhou C, Zhang J, Luo P, et al: Osteosarcoma
metastasis: prospective role of ezrin. Tumour Biol. 35:5055–5059.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Scott MC, Sarver AL, Tomiyasu H, Cornax I,
Van Etten J, Varshney J, O'Sullivan MG, Subramanian S and Modiano
JF: Aberrant retinoblastoma (RB)-E2F transcriptional regulation
defines molecular phenotypes of osteosarcoma. J Biol Chem.
290:28070–28083. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Del Mare S, Husanie H, Iancu O, Abu-Odeh
M, Evangelou K, Lovat F, Volinia S, Gordon J, Amir G, Stein J, et
al: WWOX and p53 dysregulation synergize to drive the development
of osteosarcoma. Cancer Res. 76:6107–6117. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Aguirre-Ghiso JA: Models, mechanisms and
clinical evidence for cancer dormancy. Nat Rev Cancer. 7:834–846.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang G, Yuan J and Li K: EMT transcription
factors: implication in osteosarcoma. Med Oncol. 30:6972013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hou CH, Lin FL, Hou SM and Liu JF: Cyr61
promotes epithelial-mesenchymal transition and tumor metastasis of
osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway. Mol
Cancer. 13:2362014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao K, Wang W, Rando OJ, Xue Y, Swiderek
K, Kuo A and Crabtree GR: Rapid and phosphoinositol-dependent
binding of the SWI/SNF-like BAF complex to chromatin after T
lymphocyte receptor signaling. Cell. 95:625–636. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Krasteva V, Buscarlet M, Diaz-Tellez A,
Bernard MA, Crabtree GR and Lessard JA: The BAF53a subunit of
SWI/SNF-like BAF complexes is essential for hemopoietic stem cell
function. Blood. 120:4720–4732. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lessard J, Wu JI, Ranish JA, Wan M,
Winslow MM, Staahl BT, Wu H, Aebersold R, Graef IA and Crabtree GR:
An essential switch in subunit composition of a chromatin
remodeling complex during neural development. Neuron. 55:201–215.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nguyen KH, Xu F, Flowers S, Williams EA,
Fritton JC and Moran E: SWI/SNF-mediated lineage determination in
mesenchymal stem cells confers resistance to osteoporosis. Stem
Cells. 33:3028–3038. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bao X, Tang J, Lopez-Pajares V, Tao S, Qu
K, Crabtree GR and Khavari PA: ACTL6a enforces the epidermal
progenitor state by suppressing SWI/SNF-dependent induction of
KLF4. Cell Stem Cell. 12:193–203. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu W, Fang L, Ouyang B, Zhang X, Zhan S,
Feng X, Bai Y, Han X, Kim H, He Q, et al: Actl6a protects embryonic
stem cells from differentiating into primitive endoderm. Stem
Cells. 33:1782–1793. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park J, Wood MA and Cole MD: BAF53 forms
distinct nuclear complexes and functions as a critical
c-Myc-interacting nuclear cofactor for oncogenic transformation.
Mol Cell Biol. 22:1307–1316. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao D, Pan C, Sun J, Gilbert C,
Drews-Elger K, Azzam DJ, Picon-Ruiz M, Kim M, Ullmer W, El-Ashry D,
et al: VEGF drives cancer-initiating stem cells through
VEGFR-2/Stat3 signaling to upregulate Myc and Sox2. Oncogene.
34:3107–3119. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yong KJ, Gao C, Lim JS, Yan B, Yang H,
Dimitrov T, Kawasaki A, Ong CW, Wong KF, Lee S, et al: Oncofetal
gene SALL4 in aggressive hepatocellular carcinoma. N Engl J
Med. 368:2266–2276. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pullar CE, Chen J and Isseroff RR: PP2A
activation by beta2-adrenergic receptor agonists: novel regulatory
mechanism of keratinocyte migration. J Biol Chem. 278:22555–22562.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fang F, Chang RM, Yu L, Lei X, Xiao S,
Yang H and Yang LY: MicroRNA-188-5p suppresses tumor cell
proliferation and metastasis by directly targeting FGF5 in
hepatocellular carcinoma. J Hepatol. 63:874–885. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Su S, Liu Q, Chen J, Chen J, Chen F, He C,
Huang D, Wu W, Lin L, Huang W, et al: A positive feedback loop
between mesenchymal-like cancer cells and macrophages is essential
to breast cancer metastasis. Cancer Cell. 25:605–620. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qiang L and He YY: Autophagy deficiency
stabilizes TWIST1 to promote epithelial-mesenchymal transition.
Autophagy. 10:1864–1865. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Horvai AE, Roy R, Borys D and O'Donnell
RJ: Regulators of skeletal development: a cluster analysis of 206
bone tumors reveals diagnostically useful markers. Mod Pathol.
25:1452–1461. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kempf-Bielack B, Bielack SS, Jürgens H,
Branscheid D, Berdel WE, Exner GU, Göbel U, Helmke K, Jundt G,
Kabisch H, et al: Osteosarcoma relapse after combined modality
therapy: an analysis of unselected patients in the Cooperative
Osteosarcoma Study Group (COSS). J Clin Oncol. 23:559–568. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee K, Shim JH, Kang MJ, Kim JH, Ahn JS,
Yoo SJ, Kwon Kim Y and Kwon H: Association of BAF53 with mitotic
chromosomes. Mol Cells. 24:288–293. 2007.PubMed/NCBI
|
|
28
|
Ferrari S, Bertoni F, Mercuri M, Picci P,
Giacomini S, Longhi A and Bacci G: Predictive factors of
disease-free survival for non-metastatic osteosarcoma of the
extremity: an analysis of 300 patients treated at the Rizzoli
Institute. Ann Oncol. 12:1145–1150. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xiao S, Chang RM, Yang MY, Lei X, Liu X,
Gao WB, Xiao JL and Yang LY: Actin-like 6A predicts poor prognosis
of hepatocellular carcinoma and promotes metastasis and
epithelial-mesenchymal transition. Hepatology. 63:1256–1271. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial- mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang W, Chen Z, Shang X, Tian D, Wang D,
Wu K, Fan D and Xia L: Sox12, a direct target of FoxQ1, promotes
hepatocellular carcinoma metastasis through up-regulating Twist1
and FGFBP1. Hepatology. 61:1920–1933. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hsu KW, Hsieh RH, Huang KH, Li Fen-Yau A,
Chi CW, Wang TY, Tseng MJ, Wu KJ and Yeh TS: Activation of the
Notch1/STAT3/Twist signaling axis promotes gastric cancer
progression. Carcinogenesis. 33:1459–1467. 2012. View Article : Google Scholar : PubMed/NCBI
|
